Organ_On_A_Chip_Teaser

Organs-on-Chips: An Alternative to 3D Bioprinting?

While 3D Printing has attracted a great deal of attention from investors because of high growth projections, 3D Bioprinting has attracted investors because of its futuristic appeal. Some companies involved in 3D Bioprinting are raising eyebrows with their lofty ambitions, like private company Modern Meadow which is looking to 3D Print leather, or publicly traded Organovo (NYSEMKT:ONVO) which hopes one day to be able to print human organs for transplant. The reality is though, that neither of these companies are anywhere near being able to 3D Bioprint at a size or economic scale to realize these aspirations. A more near-term use for 3D Bioprinting is to create small samples of organ tissues that can potentially be used for drug testing. Organovo plans to launch its upcoming 3D Human Liver Tissue before the end of 2014, and there are many other companies involved in 3D Bioprinting that could look to enter this space [...]

Solexel_Teaser

Solexel Grows Cheap Solar Cells Using Silicon Gas

Solar ETFs have been on a tear since the beginning of 2013 with the Guggenheim Solar ETF (NYSEARCA:TAN) having returned over +120% to date. However investors who would have bought and held this same ETF when it debuted in April of 2008 to the present day would have paper losses of -84%, even with the benefits of diversification that ETFs offer. Venture capitalists are even more gun shy with private companies such as Konarka, the solar cell manufacturer which was co-founded by a Nobel laureate and took in $200 million from the likes of Total, Chevron, and Draper Fisher Jurvetson, having declared bankruptcy in 2012 with almost no salvageable value. One private solar cell manufacturer with strong backing and a follow on round of funding announced just today is Solexel.       About Founded in 2007, Milpitas, California based Solexel has developed a unique process to manufacture high [...]

Organ_On_A_Chip_Teaser

Organs-on-Chips: An Alternative to 3D Bioprinting?

While 3D Printing has attracted a great deal of attention from investors because of high growth projections, 3D Bioprinting has attracted investors because of its futuristic appeal. Some companies involved in 3D Bioprinting are raising eyebrows with their lofty ambitions, like private company Modern Meadow which is looking to 3D Print leather, or publicly traded Organovo (NYSEMKT:ONVO) which hopes one day to be able to print human organs for transplant. The reality is though, that neither of these companies are anywhere near being able to 3D Bioprint at a size or economic scale to realize these aspirations. A more near-term use for 3D Bioprinting is to create small samples of organ tissues that can potentially be used for drug testing. Organovo plans to launch its upcoming 3D Human Liver Tissue before the end of 2014, and there are many other companies involved in 3D Bioprinting that could look to enter this space [...]

FEIC_Teaser

FEIC: Supplying the Picks and Shovels for Nanotechnology

In the 1850s during the time of the gold rush, one businessman realized he could make the same amount of money from the gold boom with far less risk by selling essentials to the miners as opposed to engaging in the risky practice of gold mining like others. Levi Strauss was his name, and went on to amass a fortune of about $163 million in today's money with his world-renound blue jeans company remaining in business still today. About 10 years ago when nanotechnology was becoming hyped throughout the investment community as the next greatest thing, one company that was often mentioned by pundits as supplying the "picks and shovels" to the development of nanotechnology was FEI Corporation (NASDAQ:FEIC). While most of the companies in the now discontinued Merrill Lynch Nanotechnology Index couldn't even manage to beat the S&P 500 returns over the past ten years, FEI was one of the four companies that [...]

FEIC_Teaser

FEIC: Supplying the Picks and Shovels for Nanotechnology

In the 1850s during the time of the gold rush, one businessman realized he could make the same amount of money from the gold boom with far less risk by selling essentials to the miners as opposed to engaging in the risky practice of gold mining like others. Levi Strauss was his name, and went on to amass a fortune of about $163 million in today's money with his world-renound blue jeans company remaining in business still today. About 10 years ago when nanotechnology was becoming hyped throughout the investment community as the next greatest thing, one company that was often mentioned by pundits as supplying the "picks and shovels" to the development of nanotechnology was FEI Corporation (NASDAQ:FEIC). While most of the companies in the now discontinued Merrill Lynch Nanotechnology Index couldn't even manage to beat the S&P 500 returns over the past ten years, FEI was one of the four companies that [...]

Lastest Articles

SunShare_Teaser

SunShare and “Community Solar Gardens”

Rooftop solar sounds like a great idea. You can have solar panels installed on your roof for no money up front and can not only power your house but also can potentially sell some of the electricity you generate back to the grid. But what if you don't have a suitable rooftop [...]

3D_Printing_Teaser

Nanotechnology Investing and Large Cap Companies

In a recent article, we highlighted the fact that the now discontinued Merrill Lynch Nanotechnology Index did not show investors superior returns when compared to the returns of the S&P 500 over the past ten years. This means that "nanotechnology investors" would have [...]